Endexx Corporation Announces Uplisting to OTCQB Venture Market

Rhea-AI Summary

Endexx Corporation has successfully uplisted from the OTC Pink Market to the OTCQB Venture Market. The uplisting was processed and approved by OTC Markets Group Inc., and the company began trading on OTCQB on July 31, 2023. This move reflects the company's commitment to enhancing transparency, increasing market visibility, and providing enhanced opportunities for shareholders.

CAVE CREEK, AZ, July 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx® Corporation (OTCQB: EDXC), a provider of innovative plant-based wellness and nutritional products, announced today that it has successfully uplisted from the OTC® Pink Market to the OTCQB® Venture Market (“OTCQB”). The uplisting was processed and approved by OTC Markets Group Inc., and the Company began trading on OTCQB® July 31, 2023. Endexx® Corporation will continue to trade under the ticker symbol “EDXC”. The OTCQB® Venture Market offers investors transparent trading in entrepreneurial and development stage U.S. and international companies that may not yet qualify for OTCQX®. To be eligible, companies must be current in their reporting and must undergo an annual verification and management certification process.

“This is a significant milestone supporting the accelerated growth of Endexx® with our uplisting to the OTCQB® Venture Market,” said Davis. “This move reflects our commitment to enhancing transparency, increasing market visibility, and providing enhanced opportunities for our shareholders. Uplisting to the OTCQB® will allow us to access a broader investor base, attract institutional investors, and improve liquidity for our stock. This action demonstrates our continued growth and solidifies our position as a trusted player in the plant based consumer products and alternative vape industries.”

www.endexx.com & www.cbdunlimited.com  

www.tryhyla.com

About Endexx® Corporation

Endexx® Corporation develops and distributes all natural, plant-derived wellness products and topical skincare products. Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness. The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption and support of skin health. www.endexx.com

Hyla currently markets its proprietary non-nicotine, guarana and L-Dopa-based vape products in a wide variety of flavors. The Hyla device is the first non-nicotine vape product to be produced in this manner in the United States and provides an unprecedented 4,500 puffs per device. Hyla is currently being distributed in 11 states and 10 countries and has signed distribution agreements with an additional nine countries The Hyla vape products bear the Underwriters Laboratories global safety certification and is CE approved.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

This presentation may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

No Offer or Solicitation. This communication shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, and, where applicable, the requirements under the securities laws of any other applicable jurisdiction.

For further information, please contact:

Endexx Corporation
IR@Endexx.com
480-595-6900

FAQ

What market did Endexx Corporation uplist to?

Endexx Corporation uplisted to the OTCQB Venture Market.

When did the company begin trading on OTCQB?

The company began trading on OTCQB on July 31, 2023.

What are the benefits of uplisting to the OTCQB Venture Market?

Uplisting to the OTCQB Venture Market allows the company to access a broader investor base, attract institutional investors, and improve liquidity for its stock.

What does the uplisting demonstrate about Endexx Corporation?

The uplisting demonstrates the company's continued growth and solidifies its position as a trusted player in the plant-based consumer products and alternative vape industries.